Data / Form D filings / Trinity Nuclein Rd III QP Investors LLC
Trinity Nuclein Rd III QP Investors LLC: Form D filing
Trinity Nuclein Rd III QP Investors LLC, a biotechnology company in Southlake, TX, filed a Form D with the SEC in 2023. The latest, on December 15, 2023, reports $2.9 million sold of a $15 million offering to 36 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2102 E STATE HWY 114, SUITE #300, Southlake, TX, 76092
- Phone
- (817) 310-2900
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Texas
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b), Investment Company Act section 3(c), section 3(c)(7)
- SEC identifier (CIK)
- 2004133
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | New notice | $15,000,000 | $2,901,272 | $12,098,728 | 36 | Dec 5, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sanjay Chandra | Executive Officer | |
| Daniel Meader | Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Dec 11, 2023 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Trinity Nuclein Rd III QP Investors LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.